investments Sakar Healthcare’s return ratios & cash flows are expected to improve significantly. Buy for target price of ₹605 (30% upside): ICICI Direct Arjun February 20, 2026 0 SHL has the capability to manufacture oral liquids, tablets, injectables, dry powder & inhaler...Read More
